Novel Noncatalytic Substrate-Selective p38α-Specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-Inflammatory Activity
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Noncatalytic Substrate-Selective p38α-Specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-Inflammatory Activity
Authors
Keywords
-
Journal
JOURNAL OF IMMUNOLOGY
Volume 198, Issue 8, Pages 3296-3306
Publisher
The American Association of Immunologists
Online
2017-03-16
DOI
10.4049/jimmunol.1602059
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic Potential of p38 MAP Kinase Inhibition in the Management of Cardiovascular Disease
- (2014) Marie Fisk et al. American Journal of Cardiovascular Drugs
- Mitochondrial p38β and Manganese Superoxide Dismutase Interaction Mediated by Estrogen in Cardiomyocytes
- (2014) Han Liu et al. PLoS One
- Determination of Protein-ligand Interactions Using Differential Scanning Fluorimetry
- (2014) Mirella Vivoli et al. Jove-Journal of Visualized Experiments
- Global analysis of phosphorylation networks in humans
- (2013) Jianfei Hu et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- DEF Pocket in p38α Facilitates Substrate Selectivity and Mediates Autophosphorylation
- (2013) Netanel Tzarum et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Emerging Role of p38 Mitogen-Activated Protein Kinase in Multiple Sclerosis and Its Models
- (2013) D. N. Krementsov et al. MOLECULAR AND CELLULAR BIOLOGY
- Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive pulmonary disease: a randomised clinical trial
- (2013) William MacNee et al. THORAX
- Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial
- (2013) Henrik Watz et al. Lancet Respiratory Medicine
- Febrile-Range Hyperthermia Modifies Endothelial and Neutrophilic Functions to Promote Extravasation
- (2012) Mohan E. Tulapurkar et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Febrile-range hyperthermia augments reversible TNF-α-induced hyperpermeability in human microvascular lung endothelial cells
- (2012) Nirav G. Shah et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- TRAF6 Protein Couples Toll-like Receptor 4 Signaling to Src Family Kinase Activation and Opening of Paracellular Pathway in Human Lung Microvascular Endothelia
- (2012) Anguo Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Toll-like Receptor Agonists and Febrile Range Hyperthermia Synergize to Induce Heat Shock Protein 70 Expression and Extracellular Release
- (2012) Aditi Gupta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Optimization of the Additive CHARMM All-Atom Protein Force Field Targeting Improved Sampling of the Backbone ϕ, ψ and Side-Chain χ1 and χ2 Dihedral Angles
- (2012) Robert B. Best et al. Journal of Chemical Theory and Computation
- Balancing target flexibility and target denaturation in computational fragment-based inhibitor discovery
- (2012) Theresa J. Foster et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- TGF- 1 Induces Endothelial Cell Apoptosis by Shifting VEGF Activation of p38MAPK from the Prosurvival p38 to Proapoptotic p38
- (2012) G. Ferrari et al. MOLECULAR CANCER RESEARCH
- p38 Mitogen-Activated Protein Kinase Pathways in Asthma and COPD
- (2011) Kian Fan Chung CHEST
- Inhibition of p38 Mitogen-Activated Protein Kinase Improves Nitric Oxide–Mediated Vasodilatation and Reduces Inflammation in Hypercholesterolemia
- (2011) Joseph Cheriyan et al. CIRCULATION
- The role of p38 mitogen-activated protein kinase in the pathogenesis of inflammatory bowel disease
- (2011) Ya Jing FENG et al. Journal of Digestive Diseases
- Mechanisms and functions of p38 MAPK signalling
- (2010) Ana Cuadrado et al. BIOCHEMICAL JOURNAL
- Two additive mechanisms impair the differentiation of 'substrate-selective' p38 inhibitors from classical p38 inhibitors in vitro
- (2010) Bart S Hendriks et al. BMC Systems Biology
- Automated Selection of Compounds with Physicochemical Properties To Maximize Bioavailability and Druglikeness
- (2010) Taiji Oashi et al. Journal of Chemical Information and Modeling
- Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: Results of two randomized, double-blind, placebo-controlled clinical studies
- (2009) Nemanja Damjanov et al. ARTHRITIS AND RHEUMATISM
- Development of Extracellular Signal-Regulated Kinase Inhibitors
- (2009) Kimberly Burkhard et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields
- (2009) K. Vanommeslaeghe et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Mitogen Activated Protein Kinase Activated Protein Kinase 2 Regulates Actin Polymerization and Vascular Leak in Ventilator Associated Lung Injury
- (2009) Mahendra Damarla et al. PLoS One
- TLR4 Signaling Is Coupled to SRC Family Kinase Activation, Tyrosine Phosphorylation of Zonula Adherens Proteins, and Opening of the Paracellular Pathway in Human Lung Microvascular Endothelia
- (2008) Ping Gong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The kinase p38α serves cell type–specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression
- (2008) Chun Kim et al. NATURE IMMUNOLOGY
- The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling
- (2008) Olga Ananieva et al. NATURE IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More